Purple Biotech (PPBT) Competitors $2.51 +0.03 (+1.21%) Closing price 04:00 PM EasternExtended Trading$2.52 +0.02 (+0.60%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PPBT vs. IBIO, MTVA, ALVR, SONN, NXTC, LPTX, IMCC, SNPX, BTAI, and NERVShould you be buying Purple Biotech stock or one of its competitors? The main competitors of Purple Biotech include iBio (IBIO), MetaVia (MTVA), AlloVir (ALVR), Sonnet BioTherapeutics (SONN), NextCure (NXTC), Leap Therapeutics (LPTX), IM Cannabis (IMCC), Synaptogenix (SNPX), BioXcel Therapeutics (BTAI), and Minerva Neurosciences (NERV). These companies are all part of the "pharmaceutical products" industry. Purple Biotech vs. Its Competitors iBio MetaVia AlloVir Sonnet BioTherapeutics NextCure Leap Therapeutics IM Cannabis Synaptogenix BioXcel Therapeutics Minerva Neurosciences iBio (NYSE:IBIO) and Purple Biotech (NASDAQ:PPBT) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, media sentiment, dividends, analyst recommendations, profitability and earnings. Do analysts recommend IBIO or PPBT? iBio currently has a consensus target price of $4.30, suggesting a potential upside of 487.43%. Purple Biotech has a consensus target price of $33.00, suggesting a potential upside of 1,214.74%. Given Purple Biotech's higher possible upside, analysts plainly believe Purple Biotech is more favorable than iBio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score iBio 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Purple Biotech 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is IBIO or PPBT more profitable? Purple Biotech's return on equity of -17.84% beat iBio's return on equity.Company Net Margins Return on Equity Return on Assets iBioN/A -73.15% -45.51% Purple Biotech N/A -17.84%-15.44% Do insiders & institutionals believe in IBIO or PPBT? 7.9% of iBio shares are held by institutional investors. Comparatively, 9.6% of Purple Biotech shares are held by institutional investors. 0.6% of iBio shares are held by company insiders. Comparatively, 3.0% of Purple Biotech shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has better earnings and valuation, IBIO or PPBT? Purple Biotech has lower revenue, but higher earnings than iBio. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioiBio$375K32.25-$24.91MN/AN/APurple BiotechN/AN/A-$7.24M-$2.62-0.96 Which has more risk & volatility, IBIO or PPBT? iBio has a beta of 0.94, meaning that its stock price is 6% less volatile than the S&P 500. Comparatively, Purple Biotech has a beta of 0.41, meaning that its stock price is 59% less volatile than the S&P 500. Does the media favor IBIO or PPBT? In the previous week, iBio and iBio both had 1 articles in the media. Purple Biotech's average media sentiment score of 1.87 beat iBio's score of 0.00 indicating that Purple Biotech is being referred to more favorably in the news media. Company Overall Sentiment iBio Neutral Purple Biotech Very Positive SummaryPurple Biotech beats iBio on 7 of the 10 factors compared between the two stocks. Get Purple Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for PPBT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PPBT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PPBT vs. The Competition Export to ExcelMetricPurple BiotechMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.41M$2.91B$5.52B$9.32BDividend YieldN/A2.46%4.25%4.05%P/E Ratio-0.9620.3628.1519.68Price / SalesN/A302.56437.63100.28Price / CashN/A42.3835.5357.53Price / Book0.207.768.235.67Net Income-$7.24M-$55.11M$3.23B$257.51M7 Day Performance1.62%0.95%-0.01%0.52%1 Month Performance1.21%8.44%5.61%8.84%1 Year PerformanceN/A-2.38%26.52%14.18% Purple Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PPBTPurple Biotech1.9466 of 5 stars$2.51+1.2%$33.00+1,214.7%N/A$6.41MN/A-0.9620IBIOiBio1.2642 of 5 stars$0.78+5.9%$4.30+448.0%-68.4%$12.96M$375K0.00100MTVAMetaVia1.7213 of 5 stars$0.62-4.0%$7.50+1,105.6%N/A$12.69MN/A0.008ALVRAlloVirN/A$2.50-2.3%N/A-85.6%$12.61MN/A-0.12110High Trading VolumeSONNSonnet BioTherapeutics3.7584 of 5 stars$4.73+20.7%$20.00+322.8%+38.4%$12.41M$20K0.0010News CoverageGap DownHigh Trading VolumeNXTCNextCure4.3512 of 5 stars$0.44+1.2%$3.50+693.5%-76.2%$12.22MN/A-0.2590Analyst ForecastGap UpLPTXLeap Therapeutics2.2265 of 5 stars$0.28-2.6%$3.38+1,089.2%-84.6%$12.07MN/A-0.1740Positive NewsIMCCIM Cannabis0.1668 of 5 stars$3.30+11.5%N/A+11.9%$11.97M$39.44M-5.16340Gap UpSNPXSynaptogenix0.3112 of 5 stars$8.50+5.2%$14.00+64.7%+130.2%$11.82MN/A-0.844Positive NewsBTAIBioXcel Therapeutics4.2198 of 5 stars$1.90-1.6%$42.60+2,142.1%-90.3%$11.69M$2.27M-0.1490Positive NewsGap UpNERVMinerva Neurosciences4.2127 of 5 stars$1.64-0.6%$5.00+204.9%-46.0%$11.54MN/A2.009Gap Down Related Companies and Tools Related Companies iBio Competitors MetaVia Competitors AlloVir Competitors Sonnet BioTherapeutics Competitors NextCure Competitors Leap Therapeutics Competitors IM Cannabis Competitors Synaptogenix Competitors BioXcel Therapeutics Competitors Minerva Neurosciences Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PPBT) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredIs this secretive Asian company trying to take over Bitcoin?A mysterious Asian conglomerate is buying billions in Bitcoin — but one legendary trader says that’s the wrong...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Purple Biotech Ltd. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Purple Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PPBT Stock Alerts